STAT April 22, 2024
Ed Silverman

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and inspiring, because that oh-too predictable routine of online meetings, phone calls, and deadlines has returned. But what can you do? The world, such as it is, continues to spin. So to give it a nudge in a better direction, we are firing up the coffee kettle to brew some cups of stimulation. Our choice today is a new addition to our overflowing pantry — honey almond. Please feel free to join us. Meanwhile, we have once again assembled a few items of interest for you. Best of luck on your journey today and, of course, do keep in touch. …

Makena, once the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
Amgen shares soar as executives outline obesity drug push
A closer look at 2023's top biopharma deals and what lies ahead
Amid buzz for Amgen's obesity drug, company sees revenue boost
Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024

Share This Article